HUMPHREY RACHEL
SEC CIK 1579781 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | Dir | 95.2K | — | $15.9K | 3 | 2023-03-24 | 2025-04-14 |
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
HUMPHREY RACHEL made no open-market trades at PYXS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-03-25 | 2025-04-14+ | PYXS | Pyxis Oncology, Inc. | HUMPHREY RACHEL | Dir | S - Sale | $1.02 | -15.5K | 95.2K | -14% | -$15.9K |
| 2024-03-28 | 2024-03-26 | PYXS | Pyxis Oncology, Inc. | HUMPHREY RACHEL | Dir | A - Grant | $0.00 | +38.7K | 96.8K | +67% | $0 | |
| 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | HUMPHREY RACHEL | Dir | A - Grant | $0.00 | +58.1K | 58.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations